Verrica Pharmaceuticals
West Chester
About Verrica Pharmaceuticals
Verrica Pharmaceuticals is a pharmaceutical company developing proprietary topical therapies for the treatment of lesional skin diseases such as Verruca vulgaris (common warts and plantar warts) and Molluscum contagiosum. Current treatment for these and similar conditions have only limited efficacy, are painful or require daily compliance for an extended treatment period to see results.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $204.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nasdaq:VRCA
- Website: verricapharmaceuticals.com
- Phone: +1 484-453-3300
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/verrica-pharmaceuticals-67095 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.